Why the study?
Heparin-induced thrombocytopenia is a rare, life-threatening adverse drug reaction, and clinicians must recognize that concomitant coronary stent and femoral artery thrombosis can occur amid widespread heparin and PCI use.
Clinicians should be aware of the rare but severe complication of HIT leading to simultaneous coronary stent and peripheral artery thrombosis following PCI.
Heparin induced thrombocytopenia (HIT) is a rare but potentially life threatening adverse drug reaction. We report an unusual case of concomitant subacute coronary stent and femoral artery thrombosis secondary to HIT. In the current era of extensive growth of heparin use and percutaneous coronary interventions, it's important for clinicians to remember that such complication might occur and should be prevented.
No takes yet. Share an insight, caveat, or question.
Messaoud et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: